Cell Therapeutics (CTIC) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cell Therapeutics (CTIC)

An SI Board Since August 1997

Posts	SubjectMarks	Bans	Symbol
946	45	0	CTIC

Emcee: Regis McConnell	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
796	Thanks Peter. That tells me CTIC's plan is no better, and even worse, than	keokalani'nui	-	2/10/2006
795	Note that women with NSLC do better than men whether or not they are treated. So	Biomaven	-	2/10/2006
794	Do you know if the company is conducting experiments to prove that? (the estrog	keokalani'nui	-	2/10/2006
793	No, I wouldn't say that. As you know, there was a positive result from the	Icebrg	-	2/10/2006
792	Has ctic shown that it is estrogen or other female-centric chemistry that allows	keokalani'nui	-	2/9/2006
791	so what does that mean in terms of product launch timing if study is as successf	sammaster	-	2/8/2006
790	XYOTAX(TM) has FDA Fast Track Designation for Women With Advanced Lung Cancer Wh	Doc Bones	-	2/8/2006
789	Dr. Socinski's presentation at the Chemotherapy Foundation Symposium is now	Icebrg	-	1/21/2006
788	Estrogen Carcinogenesis in Breast Cancer James D. Yager, Ph.D., and Nancy E. Dav	Icebrg	-	1/18/2006
787	so would they have to do a whole full phase 3 trial over again to prove non-infe	sammaster	-	1/17/2006
786	A trial can be designed to show superiority, non-inferiority, or either, but the	DewDiligence_on_SI	-	1/17/2006
785	i agree that insider selling is not a bullish sign.. but he has over 880 thousan	sammaster	-	1/16/2006
784	When an insider sells at this price level after all we have been through, it rai	ddoug	-	1/16/2006
783	so.. bull side phase 3 pixantrone xyotax in women bear side debt dilution ? ma	sammaster	-	1/16/2006
782	Well, if they had been able to support their claim for non-inferiority, I think	Icebrg	-	1/16/2006
781	so because the initial trial was not set up to show non-inferiority, they cannot	sammaster	-	1/16/2006
780	The company will not file based on non-inferiority claims in the US, which means	Icebrg	-	1/16/2006
779	so from what i understand...regarding xyotax phase 3 trials failed to show survi	sammaster	-	1/16/2006
778	Thanks. Was interested from the M side, for whom a little money would be a lot.	keokalani'nui	-	1/10/2006
777	Wilder I believe the matter is still unresolved. In its latest 10Q the company	Icebrg	-	1/10/2006
776	Erik, Do you know if the Micromet suit was ever resolved? (Was not in time for	keokalani'nui	-	1/10/2006
775	*DJ Cell Therapeutics Registers $82M Conv Notes For Holders 16 Dec 17:18 DJ Ce	LJM	-	12/16/2005
774	SABCS: Herceptin-Anthracycline Cardiotoxicity Called Real and Persistent [Genen	Icebrg	-	12/9/2005
773	Researchers Probe Links Between Gender and Cancer Women Lung-Cancer Patients May	Icebrg	-	12/6/2005
772	A little bit of both, I guess. To keep the CEO's toys, while letting half th	Icebrg	-	11/29/2005

Go to reply# or date (mm/dd/yy):